Does YAZ Cause Mobility decreased? 5 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Mobility decreased have been filed in association with YAZ. This represents 0.3% of all adverse event reports for YAZ.
5
Reports of Mobility decreased with YAZ
0.3%
of all YAZ reports
1
Deaths
5
Hospitalizations
How Dangerous Is Mobility decreased From YAZ?
Of the 5 reports, 1 (20.0%) resulted in death, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for YAZ. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does YAZ Cause?
Injury (1,162)
Pain (1,142)
Emotional distress (795)
Deep vein thrombosis (609)
Pulmonary embolism (585)
Anxiety (554)
Cholecystitis chronic (414)
Thrombosis (267)
General physical health deterioration (262)
Gallbladder disorder (241)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)